Serveur d'exploration H2N2 - Exploration (Accueil)

Index « MeshFr.i » - entrée « Adulte d'âge moyen »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Adulte < Adulte d'âge moyen < Affinité des anticorps  Facettes :

List of bibliographic references indexed by Adulte d'âge moyen

Number of relevant bibliographic references: 46.
Ident.Authors (with country if any)Title
000166 (2018) Tara M. Babu [États-Unis] ; Ranawaka A P M. Perera ; Joseph T. Wu ; Theresa Fitzgerald [États-Unis] ; Carolyn Nolan [États-Unis] ; Benjamin J. Cowling ; Scott Krauss [États-Unis] ; John J. Treanor [États-Unis] ; Malik PeirisPopulation Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment
000220 (2018) Guo Luo ; Aditya Ambati ; Ling Lin ; Mélodie Bonvalet ; Markku Partinen [Finlande] ; Xuhuai Ji ; Holden Terry Maecker ; Emmanuel Jean-Marie MignotAutoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy
000274 (2017) Gerardo Chowell ; Lone Simonsen ; Rodrigo Fuentes ; Jose Flores ; Mark A. Miller ; Cécile ViboudSevere mortality impact of the 1957 influenza pandemic in Chile
000305 (2017) Dennis E. Te Beest [Pays-Bas] ; Erwin De Bruin [Pays-Bas] ; Sandra Imholz [Pays-Bas] ; Marion Koopmans [Pays-Bas] ; Michiel Van Boven [Pays-Bas]Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2)
000406 (2016) Wei Wang ; Esmeralda Alvarado-Facundo ; Qiong Chen ; Christine M. Anderson [États-Unis] ; Dorothy Scott [États-Unis] ; Russell Vassell ; Carol D. WeissSerum Samples From Middle-aged Adults Vaccinated Annually with Seasonal Influenza Vaccines Cross-neutralize Some Potential Pandemic Influenza Viruses.
000421 (2016) April J. Cobos [États-Unis] ; Clinton G. Nelson [États-Unis] ; Megan Jehn [États-Unis] ; Cécile Viboud [États-Unis] ; Gerardo Chowell [États-Unis]Mortality and transmissibility patterns of the 1957 influenza pandemic in Maricopa County, Arizona
000522 (2015) Yulia A. Desheva [Russie] ; Tatiana A. Smolonogina [Russie] ; Svetlana A. Donina [Russie] ; Larisa G. Rudenko [Russie]Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers
000562 (2015) Cécile Viboud [États-Unis] ; Lone Simonsen [États-Unis, Danemark] ; Rodrigo Fuentes ; Jose Flores [Chili] ; Mark A. Miller [États-Unis] ; Gerardo Chowell [États-Unis]Global Mortality Impact of the 1957–1959 Influenza Pandemic
000563 (2015) Irina Kiseleva [Russie] ; Irina Dubrovina [Russie] ; Ekaterina Fedorova [Russie] ; Natalie Larionova [Russie] ; Irina Isakova-Sivak [Russie] ; Ekaterina Bazhenova [Russie] ; Maria Pisareva [Russie] ; Victoria Kuznetsova [Russie] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie]Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
000602 (2015) Mariana Baz [États-Unis] ; Myeisha Paskel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; James R. Zengel [États-Unis] ; Xing Cheng [États-Unis] ; John J. Treanor [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [Indonésie]A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets.
000691 (2014) Gerald Aichinger [Autriche] ; Barbara Grohmann-Izay [Autriche] ; Maikel V. W. Van Der Velden [Autriche] ; Sandor Fritsch [Autriche] ; Manuela Koska [Autriche] ; Daniel Portsmouth [Autriche] ; Mary Kate Hart [États-Unis] ; Wael El-Amin [États-Unis] ; Otfried Kistner [Autriche] ; P. Noel Barrett [Autriche]Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults
000833 (2013) Alexandru Coman [Roumanie] ; Daniel N. Maftei ; Whitney S. Krueger ; Gary L. Heil ; John A. Friary ; Razvan M. Chereches ; Emanuela Sirlincan ; Paul Bria ; Claudiu Dragnea ; Iosif Kasler ; Gregory C. GraySerological evidence for avian H9N2 influenza virus infections among Romanian agriculture workers.
000859 (2013) Matthew S. Miller [États-Unis] ; Thomas J. Gardner [États-Unis] ; Florian Krammer [États-Unis] ; Lauren C. Aguado [États-Unis] ; Domenico Tortorella [États-Unis] ; Christopher F. Basler [États-Unis] ; Peter Palese [États-Unis]Neutralizing antibodies against previously-encountered influenza virus strains increase over time: A longitudinal analysis
000A04 (2012) Tom Reichert [États-Unis] ; Gerardo Chowell [États-Unis] ; Jonathan A. Mccullers [États-Unis]The age distribution of mortality due to influenza: pandemic and peri-pandemic
000A27 (2012) Filippo Ansaldi [Italie] ; Laura Valle ; Daniela De Florentiis ; Valentina Parodi ; Giuseppe Murdaca ; Bianca Bruzzone ; Paolo Durando ; Maurizio Setti ; Giancarlo IcardiPhase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults.
000C86 (2011) Chao Qiu ; Yang Huang [République populaire de Chine] ; Qian Wang [République populaire de Chine] ; Di Tian ; Wanju Zhang ; Yunwen Hu ; Zhenghong Yuan ; Xiaoyan Zhang ; Jianqing XuBoosting Heterosubtypic Neutralization Antibodies in Recipients of 2009 Pandemic H1N1 Influenza Vaccine
000D93 (2010) N A Mazurkova ; N N Ryndiuk ; L N Shishkina ; V A Ternovo ; Iu V. Tumanov ; L E Bulychev ; M O Skarnovich ; A S Kabanov ; S G Panchenko ; R P Ale Nikov ; T N Il'Ina ; V I Kuzubov ; S Ia Mel'Nikov ; A N Mironov ; S A Korovkin ; A N Sergeev ; I G Drozdov[Results of clinical trials on reactogenicity, safety, and immunogenicity of influenza allantoic intranasal live vaccine "Ultragrivac" (type A/H5N2)].
000E24 (2010) Ana Clara Monsalvo [Argentine] ; Juan P. Batalle [Argentine] ; M. Florencia Lopez [Argentine] ; Jens C. Krause [États-Unis] ; Jennifer Klemenc [États-Unis] ; Johanna Zea [Argentine, États-Unis] ; Bernardo Maskin [Argentine] ; Jimena Bugna [Argentine] ; Carlos Rubinstein [Argentine] ; Leandro Aguilar [Argentine] ; Liliana Dalurzo [Argentine] ; Romina Libster [Argentine] ; Vilma Savy [Argentine] ; Elsa Baumeister [Argentine] ; Liliana Aguilar [Argentine] ; Graciela Cabral [Argentine] ; Julia Font [Argentine] ; Liliana Solari [Argentine] ; Kevin P. Weller [États-Unis] ; Joyce Johnson [États-Unis] ; Marcela Echavarria [Argentine] ; Kathryn M. Edwards [États-Unis] ; James D. Chappell [États-Unis] ; James E. Crowe [États-Unis] ; John V. Williams [États-Unis] ; Guillermina A. Melendi [Argentine, États-Unis] ; Fernando P. Polack [Argentine, États-Unis]Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes
000E74 (2010) N. Ikonen [Finlande] ; M. Strengell ; L. Kinnunen ; P. Osterlund ; J. Pirhonen ; M. Broman ; I. Davidkin ; T. Ziegler ; I. JulkunenHigh frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland.
001062 (2009) Ilaria Capua [Italie] ; Anna Kajaste-Rudnitski [Italie] ; Elena Bertoli [Italie] ; Elisa Vicenzi [Italie]Pandemic Vaccine Preparedness—Have We Left Something Behind?
001132 (2009) Kawsar R. Talaat [États-Unis] ; Ruth A. Karron ; Karen A. Callahan ; Catherine J. Luke ; Susan C. Dilorenzo ; Grace L. Chen ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; Brian R. Murphy ; George Kemble ; Kanta SubbaraoA live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.
001373 (2007) Fred Y. Aoki [Canada] ; Guy Boivin ; Noel RobertsInfluenza virus susceptibility and resistance to oseltamivir.
001382 (2007) Michael J. Haber [États-Unis] ; Davis K. Shay [États-Unis] ; Xiaohong M. Davis [États-Unis] ; Rajan Patel [États-Unis] ; Xiaoping Jin [États-Unis] ; Eric Weintraub [États-Unis] ; Evan Orenstein [États-Unis] ; William W. Thompson [États-Unis]Effectiveness of Interventions to Reduce Contact Rates during a Simulated Influenza Pandemic
001443 (2007) Declan ButlerCheaper approaches to flu divide researchers
001492 (2006) Monika Lindemann [Allemagne] ; Oliver Witzke ; Peter Lütkes ; Melanie Fiedler ; Ernst Kreuzfelder ; Thomas Philipp ; Michael Roggendorf ; Hans Grosse-WildeELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients.
001513 (2006) Suzanne L. Epstein [États-Unis]Prior H1N1 Influenza Infection and Susceptibility of Cleveland Family Study Participants during the H2N2 Pandemic of 1957: An Experiment of Nature
001587 (2005) Rajan Patel [États-Unis] ; Ira M. Longini ; M Elizabeth HalloranFinding optimal vaccination strategies for pandemic influenza using genetic algorithms.
001690 (2004) Ira M. Longini ; M. Elizabeth Halloran ; Azhar Nizam ; Yang YangContaining Pandemic Influenza with Antiviral Agents
001771 (2002) N. Hehme [Allemagne] ; H. Engelmann [Allemagne] ; W. Künzel [Allemagne] ; E. Neumeier [Allemagne] ; R. S Nger [Allemagne]Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines
001797 (2001) L R Yeolekar [Inde] ; P B Kulkarni ; M S Chadha ; B L RaoSeroepidemiology of influenza in Pune, India.
001A53 (1998) Lone Simonsen [Géorgie (pays)] ; Matthew J. Clarke [Géorgie (pays)] ; Lawrence B. Schonberger [Géorgie (pays)] ; Nancy H. Arden [Géorgie (pays)] ; Nancy J. Cox [Géorgie (pays)] ; Keiji Fukuda [Géorgie (pays), États-Unis]Pandemic versus Epidemic Influenza Mortality: A Pattern of Changing Age Distribution
001B22 (1997) K. Hashigucci ; S. Tamura ; T. Kurata ; H. Kamiya ; T. Ishidate[Efficacy of nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin in healthy volunteers].
001E68 (1993) Louis F. Fries [États-Unis] ; Susan B. Dillon [États-Unis] ; James E. K. Hildreth [États-Unis] ; Ruth A. Karron [États-Unis] ; Ann W. Funkhouser [États-Unis] ; Carl J. Friedman [États-Unis] ; Christopher S. Jones [États-Unis] ; Vasantha G. Culleton [États-Unis] ; Mary Lou Clements [États-Unis]Safety and Immunogenicity of a Recombinant Protein Influenza A Vaccine in Adult Human Volunteers and Protective Efficacy against Wild-Type H1N1 Virus Challenge
002310 (1987) R. E. Hope-Simpson [Royaume-Uni] ; D. B. Golubev [Russie]A new concept of the epidemic process of influenza A virus
002531 (1984) R. E. Hope-SimpsonAge and secular distributions of virus-proven influenza patients in successive epidemics 1961–1976 in Cirencester: Epidemiological significance discussed
002658 (1982) M. Rekart [États-Unis] ; K. Rupnik [États-Unis] ; T C. Cesario [États-Unis] ; J G Tilles [États-Unis]PREVALENCE OF HEMAGGLUTINATION INHIBITION ANTIBODY TO CURRENT STRAINS OF THE H3N2 AND H1N1 SUBTYPES OF INFLUENZA A VIRUS IN SERA COLLECTED FROM THE ELDERLY IN 1976
002779 (1980) A S Beare ; A P Kendal ; N J Cox ; C. ScholtissekHuman trials with wild-type H1N1 and recombinant H3N2-H1N1 influenza A viruses of 1977-1978.
002871 (1979) M L Profeta ; D. De Vito ; M. Fasan[Serologic survey of human type A influenza virus infection following 10-year periods of prevalence of H3N2 strains].
002955 (1979) W. M. Marine ; J. E. ThomasAntigenic memory to influenza A viruses in man determined by monovalent vaccines.
002A41 (1977) R J Marttila ; P. Halonen ; U K RinneInfluenza virus antibodies in Parkinsonism. Comparison of postencephalic and idiopathic Parkinson patients and matched controls.
002A70 (1977) Colin Mclaren [États-Unis] ; Martha W. Verbonitz [États-Unis] ; Sylvester Daniel [États-Unis] ; George E. Grubbs [États-Unis] ; Francis A. Ennis [États-Unis]Effect of Priming Infection on Serologic Response to Whole and Subunit Influenza Virus Vaccines in Animals
002A78 (1977) Gary R. Noble [Géorgie (pays), États-Unis] ; Harold S. Kaye [Géorgie (pays)] ; Alan P. Kendal [Géorgie (pays)] ; Walter R. Dowdle [Géorgie (pays)]Age-Related Heterologous Antibody Responses to Influenza Virus Vaccination
002D92 (????) A N Na Khin ; L G Katorgina ; T N Kim ; I M Krotova ; G M Denisov ; N V Trusov ; V N Reznik[Regularities of formation in a general population of serum antibodies to previously circulated influenza A viruses].
002E18 (????) A N Na Khin ; S A Donina ; G D Petukhova ; E M Koren'Kov ; E M Doroshenko ; E P Grigor'Eva ; M A Suvorova ; L G Rudenko[Humoral and cell-mediated immune responses in humans to the A/California/07/ 2009 (H1N1) virus, A(H1N1)pdm2009].
002E26 (????) T A Smolonogina ; Iu A. Desheva ; A R Rekstin ; A N Mironov ; L G Rudenko[Evaluation of the anti-neuraminidase antibodies in clinical trials of the live influenza vaccine of the A(H5N2) subtype].
002E45 (????) Z. Nikolova ; L Ia Zakstel'Skaia ; R. Kotseva ; E V Molibog[Age profile of the antihemagglutinins and antineuraminidase antibodies in type A influenza (author's transl)].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Adulte d'âge moyen" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Adulte d'âge moyen" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Adulte d'âge moyen
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021